Zhang Hongming, Wu Songlin, Huang Congxing, Li Xiaoyan
Department of Cardiology, The General Hospital of Jinan Military Region, Jinan, Shandong 250031, P.R. China.
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Mol Med Rep. 2014 May;9(5):1959-67. doi: 10.3892/mmr.2014.2001. Epub 2014 Feb 28.
The present study aimed to determine the effect of chronic treatment with losartan on transient outward potassium current (Ito) and the expression levels of potassium voltage-gated channel subfamily D members 2 and 3 (Kv4.2 and 3) and voltage-gated potassium channel-interacting protein 2 (KChIP2) in rats. Spontaneously hypertensive (SH) rats and Wistar-Kyoto (WKY) rats were used in the study. The rats were divided into lo-SH and SH groups and los-WKY and WKY groups, respectively. Ito was recorded and expression levels of Kv4.2, Kv4.3 and KChIP2 were measured by western blot analysis and quantitative polymerase chain reaction. Ito current density was smaller in SH compared with WKY, los-WKY and los-SH groups (P<0.01). Inactivation time constant of myocytes was larger in SH compared with WKY, los-WKY and los-SH groups (P<0.01). The mean levels of mRNA and protein of Kv4.2 and Kv4.3 were significantly lower in the SH compared with WKY, los-WKY and los‑SH groups in vivo and in vitro (P<0.01). The Pearson statistical test showed no correlation between the expression levels of Kv4.2, Kv4.3, KChIP2 and the changes in blood pressure in the losartan treatment group. In conclusion, chronic blockade of angiotensin II type 1 receptors with losartan reversed SH rats' electrical remodeling and shortened action potential duration, which was associated with an increase in Ito density as the expression levels of Kv4.2, Kv4.3 increased and the expression levels of KChIP2 decreased. However, the expression levels of Kv4.2, Kv4.3 and KChIP2 were not correlated with the change in blood pressure in the losartan treatment group. Losartan may decrease the inactivation time by increasing the expression of KChIP2.
本研究旨在确定氯沙坦长期治疗对大鼠瞬时外向钾电流(Ito)以及钾电压门控通道亚家族D成员2和3(Kv4.2和Kv4.3)和电压门控钾通道相互作用蛋白2(KChIP2)表达水平的影响。本研究使用了自发性高血压(SH)大鼠和Wistar-Kyoto(WKY)大鼠。大鼠分别分为氯沙坦-SH组和SH组以及氯沙坦-WKY组和WKY组。通过膜片钳记录Ito,并采用蛋白质免疫印迹分析和定量聚合酶链反应测量Kv4.2、Kv4.3和KChIP2的表达水平。与WKY组、氯沙坦-WKY组和氯沙坦-SH组相比,SH组的Ito电流密度较小(P<0.01)。与WKY组、氯沙坦-WKY组和氯沙坦-SH组相比,SH组心肌细胞的失活时间常数更大(P<0.01)。在体内和体外,与WKY组、氯沙坦-WKY组和氯沙坦-SH组相比,SH组中Kv4.2和Kv4.3的mRNA和蛋白平均水平显著降低(P<0.01)。Pearson统计检验显示,氯沙坦治疗组中Kv4.2、Kv4.3、KChIP2的表达水平与血压变化之间无相关性。总之,氯沙坦长期阻断1型血管紧张素II受体可逆转SH大鼠的电重构并缩短动作电位时程,这与Ito密度增加有关,同时Kv4.2、Kv4.3表达水平升高,KChIP2表达水平降低。然而,氯沙坦治疗组中Kv4.2、Kv4.3和KChIP2的表达水平与血压变化无关。氯沙坦可能通过增加KChIP2的表达来缩短失活时间。